Acer Medical Inc.

Taipei Exchange:6857.TWO

Sector

🏥 Health Care

Industries

🤖 Artificial Intelligence (AI)

📊 Big Data

🔬 Clinical Trials

🏥 Hospitals & Clinics

💻 Telehealth

Location

Taiwan

Market Cap

USD 66.23 M

Share Price

USD 4.35

Avg Daily Volume

3,093

Change (1 day)

1.07%

Change (1 year)

-18.91%

Change (YTD)

0.42%

Acer Medical Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2024: USD 1.07 M

Acer Medical Inc. Selling, General, and Administrative Expenses (SG&A) is USD 1.07 M for the year ending December 31, 2024, a -2.29% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.

Acer Medical Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2023 was USD 1.09 M, a -4.42% change year over year.
Acer Medical Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2022 was USD 1.14 M, a 137.40% change year over year.
Acer Medical Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2021 was USD 481.05 K, a 859.63% change year over year.
Acer Medical Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2020 was USD 50.13 K.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Selling, General, and Administrative Expenses (SG&A)	Research and Development (R&D) Expenses	Revenue	Revenue

Taipei Exchange: 6857.TWO

Acer Medical Inc.

CEO	Mr. Yin Xiong Xu
IPO Date	March 4, 2022
Location	Taiwan
Headquarters	No. 88, Section 1, Xintai 5th Road
Employees	22
Sector	🏥 Health Care
Industries Artificial Intelligence (AI) 📊 Big Data 🔬 Clinical Trials 🏥 Hospitals & Clinics 💻 Telehealth

Description

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.